Brain Cancer | Specialty

The OncLive Brain Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of brain cancer, including glioma, glioblastoma multiforme, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

"Trojan Horse" Tested in EGFR-Amplified Glioblastoma

July 6th 2017

Investigators are seeking to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide will improve the survival of patients with newly diagnosed glioblastoma multiforme with EGFR amplification.

Tumor Treating Fields Substantially Improve Survival in GBM

April 3rd 2017

Tumor treating fields reduced the risk of death by 37% and overall survival was extended by a median of 5 months for patients with glioblastoma multiforme, in a landmark analysis of the EF-14 trial.

Dr. Stupp on Final Results for TTFields Added to Chemo in Glioblastoma

April 2nd 2017

Roger Stupp, MD, professor, Neurological Surgery, and associate director, Strategic Initiatives, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, discusses final results of a randomized, multi-center, phase III trial investigating tumor treating fields (TTFields) added to standard chemotherapy in newly diagnosed glioblastoma during the AACR Annual Meeting.

Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer

March 1st 2017

A brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem cells, combined with analysis of patient-matched serum-cultured GBM and an annotated GBM tissue microarray, to identify clinically relevant biomarkers.

Metabolic Pathways May Lead Researchers to Novel Therapeutic Targets in Neuro-Oncology

December 26th 2016

In neuro-oncology, newfound interest has sparked investigations into metabolic pathways in tumors with the hope of identifying novel therapeutic targets.

Onartuzumab Shows No Additional Benefit When Combined With Bevacizumab in GBM

December 23rd 2016

The addition of onartuzumab to bevacizumab did not provide any increased clinical benefit in the treatment of patients with recurrent glioblastoma multiforme.

The Future of Glioblastoma

December 21st 2016

Emerging Vaccines in Glioblastoma

December 21st 2016

Glioblastoma: The Potential Role of Immunotherapy

December 21st 2016

Overcoming Challenges in Glioblastoma

December 21st 2016

Glioblastoma: Educating Patients on Tumor-Treating Field Therapy

December 21st 2016

Practical Experience With Optune in Glioblastoma

December 21st 2016

Tumor-Treating Field Therapy in Glioblastoma: Patient Selection

December 21st 2016

New Long-term Data for Tumor-Treating Fields in Glioblastoma

December 21st 2016

Glioblastoma: Impact of Tumor-Treating Field Therapy

December 21st 2016

The Role of Chemoradiotherapy in Glioblastoma

December 21st 2016

Glioblastoma: Guideline Recommendations for Treatment

December 21st 2016

Classification and Prognosis of Glioblastoma

December 21st 2016

Glioblastoma: The Role of Resection

December 21st 2016

Multidisciplinary Care in Glioblastoma

December 21st 2016